Researchers Chafe at Halt of Psychiatric Trials

(Nature) – University of Minnesota psychiatrist Kathryn Cullen had just started recruiting volunteers for the first clinical trial of the anaesthetic ketamine against treatment-resistant depression in adolescents when the university’s administration stopped the study in its tracks. On 18 March she received a surprising letter from the university president announcing that he was “suspending enrollment in all Department of Psychiatry interventional drug studies currently active or awaiting approval.”

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.